Skip to Main Content

Paper Details

Phase I study of sapanisertib with carboplatin and paclitaxel in mTOR pathway altered solid malignancies.
NPJ Precis Oncol
1
2023
Author NameAffiliation
Jordi RodonUniversity of Texas MD Anderson Cancer Center
Shubham PantUniversity of Texas MD Anderson Cancer Center
Funda Meric-BernstamUniversity of Texas MD Anderson Cancer Center
  • 1 - 3

Datasets

Release 1.2